| 一般的な頻出語を「文章内」のリストから除外しています |
| 2語前 |
1語前 |
|
1語後 |
2語後 |
|
文章内 |
| it |
33 |
has |
147 |
|
a |
117 |
in |
54 |
|
cells |
97 |
| the |
32 |
to |
70 |
|
more |
85 |
to |
44 |
|
increasingly |
82 |
| and |
27 |
have |
67 |
|
increasingly |
69 |
and |
35 |
|
important |
70 |
| that |
17 |
is |
50 |
|
an |
61 |
important |
31 |
|
during |
58 |
| cells |
15 |
and |
34 |
|
the |
30 |
that |
19 |
|
cell |
51 |
| as |
14 |
that |
28 |
|
available |
27 |
with |
19 |
|
data |
50 |
| has |
13 |
are |
24 |
|
less |
16 |
by |
19 |
|
patients |
46 |
| which |
13 |
can |
20 |
|
clear |
13 |
at |
16 |
|
available |
43 |
| potential |
11 |
may |
14 |
|
possible |
12 |
of |
15 |
|
high |
41 |
| of |
9 |
it |
13 |
|
important |
12 |
common |
13 |
|
over |
40 |
| this |
7 |
which |
12 |
|
activated |
10 |
for |
13 |
|
however |
40 |
| 2 |
6 |
they |
12 |
|
resistant |
10 |
more |
13 |
|
show |
39 |
| have |
6 |
will |
12 |
|
apparent |
9 |
during |
10 |
|
disease |
36 |
| they |
6 |
could |
12 |
|
one |
9 |
on |
8 |
|
treatment |
36 |
| sequencing |
5 |
also |
10 |
|
infected |
8 |
when |
7 |
|
time |
35 |
| a |
5 |
cells |
10 |
|
highly |
6 |
increasingly |
7 |
|
cancer |
34 |
| when |
5 |
who |
9 |
|
limiting |
6 |
most |
7 |
|
years |
33 |
| before |
5 |
recently |
8 |
|
dysfunctional |
5 |
popular |
6 |
|
into |
33 |
| these |
5 |
from |
8 |
|
pregnant |
5 |
as |
6 |
|
associated |
31 |
| environments |
4 |
or |
8 |
|
critical |
5 |
standard |
5 |
|
health |
31 |
| data |
4 |
then |
7 |
|
smaller |
5 |
upon |
5 |
|
research |
30 |
| patients |
4 |
but |
7 |
|
very |
5 |
major |
5 |
|
tool |
30 |
| to |
4 |
might |
5 |
|
progressively |
5 |
prevalent |
5 |
|
one |
29 |
| is |
4 |
rapidly |
5 |
|
better |
5 |
powerful |
5 |
|
species |
28 |
| therapies |
4 |
not |
5 |
|
ubiquitous |
4 |
available |
5 |
|
protein |
28 |
| interactions |
3 |
now |
4 |
|
crucial |
4 |
valuable |
5 |
|
analysis |
27 |
| but |
3 |
proteins |
4 |
|
of |
4 |
clear |
5 |
|
many |
27 |
| ms |
3 |
virus |
3 |
|
stronger |
4 |
pronounced |
5 |
|
conditions |
27 |
| 1 |
3 |
should |
3 |
|
trapped |
4 |
after |
5 |
|
studies |
26 |
| or |
3 |
genes |
3 |
|
powerful |
4 |
over |
4 |
|
human |
26 |
| species |
3 |
networks |
3 |
|
essential |
4 |
apparent |
4 |
|
both |
26 |
| bacteria |
3 |
data |
3 |
|
commonplace |
3 |
significant |
4 |
|
potential |
26 |
| do |
3 |
individuals |
3 |
|
dependent |
3 |
key |
4 |
|
response |
26 |
| testing |
3 |
food |
3 |
|
competent |
3 |
critical |
4 |
|
other |
25 |
| changes |
3 |
analysis |
2 |
|
disrupted |
3 |
complex |
4 |
|
global |
25 |
| such |
3 |
subsequently |
2 |
|
unstable |
3 |
from |
4 |
|
less |
25 |
| level |
3 |
ankle |
2 |
|
accessible |
3 |
promising |
4 |
|
target |
25 |
| analysis |
3 |
sources |
2 |
|
established |
3 |
or |
4 |
|
using |
25 |
| different |
3 |
often |
2 |
|
challenging |
3 |
indispensable |
4 |
|
new |
25 |
| how |
3 |
models |
2 |
|
ever |
3 |
relevant |
4 |
|
clinical |
24 |
| expected |
3 |
later |
2 |
|
widely |
3 |
alternative |
4 |
|
specific |
24 |
| those |
2 |
would |
2 |
|
acutely |
3 |
established |
4 |
|
due |
24 |
| neurons |
2 |
environment |
2 |
|
fixed |
3 |
tools |
4 |
|
early |
24 |
| lipid |
2 |
complex |
2 |
|
recognized |
3 |
variable |
3 |
|
used |
24 |
| knowledge |
2 |
therefore |
2 |
|
detectable |
3 |
severe |
3 |
|
based |
24 |
| reporters |
2 |
this |
2 |
|
overwhelmed |
3 |
the |
3 |
|
drug |
24 |
| needs |
2 |
of |
2 |
|
feasible |
3 |
within |
3 |
|
common |
23 |
| pathways |
2 |
thus |
2 |
|
phosphorylated |
3 |
but |
3 |
|
before |
23 |
| disease |
2 |
decline |
2 |
|
difficult |
3 |
prominent |
3 |
|
first |
23 |
| antibodies |
2 |
effects |
2 |
|
stabilized |
3 |
main |
3 |
|
therapy |
22 |
| once |
2 |
artery |
2 |
|
de |
2 |
if |
3 |
|
development |
22 |
| imaging |
2 |
quickly |
2 |
|
pathogenic |
2 |
preferred |
3 |
|
complex |
22 |
| associated |
2 |
features |
2 |
|
associated |
2 |
dependent |
3 |
|
therapeutic |
22 |
| abeta |
2 |
humans |
2 |
|
dominant |
2 |
understood |
3 |
|
severe |
22 |
| proteins |
2 |
associations |
2 |
|
cloud |
2 |
sensitive |
3 |
|
large |
22 |
| cancer |
2 |
children |
2 |
|
physiologically |
2 |
great |
3 |
|
recently |
21 |
| actin |
2 |
responses |
2 |
|
dorsiflexed |
2 |
mature |
3 |
|
change |
21 |
| phenotypes |
2 |
1 |
2 |
|
unresponsive |
2 |
into |
3 |
|
systems |
21 |
| resolution |
2 |
sequencing |
2 |
|
much |
2 |
leading |
3 |
|
non |
21 |
| genomes |
2 |
tests |
2 |
|
abnormal |
2 |
global |
3 |
|
possible |
21 |
| specific |
2 |
effect |
2 |
|
further |
2 |
cells |
3 |
|
results |
21 |
| treatment |
2 |
datasets |
2 |
|
independent |
2 |
used |
3 |
|
genes |
21 |
| women |
2 |
applications |
2 |
|
near |
2 |
primary |
3 |
|
upon |
21 |
| effects |
2 |
mutations |
2 |
|
destabilized |
2 |
similar |
3 |
|
biological |
21 |
| macrophages |
2 |
either |
2 |
|
incorporated |
2 |
infected |
3 |
|
although |
21 |
| obesity |
2 |
dna |
2 |
|
sensitized |
2 |
than |
3 |
|
information |
20 |
| however |
2 |
climate |
2 |
|
manifest |
2 |
which |
3 |
|
clear |
20 |
| environment |
2 |
course |
1 |
|
memory |
2 |
effective |
3 |
|
through |
20 |
| research |
2 |
c |
1 |
|
mandatory |
2 |
frequent |
3 |
|
t |
20 |
| learning |
2 |
methylation |
1 |
|
longer |
2 |
research |
3 |
|
resistant |
20 |
| cvd |
2 |
change |
1 |
|
maladaptive |
2 |
increasing |
3 |
|
dna |
20 |
| devices |
2 |
generally |
1 |
|
ill |
2 |
essential |
3 |
|
highly |
19 |
| g |
2 |
tones |
1 |
|
particularly |
2 |
under |
3 |
|
activated |
19 |
| some |
2 |
before |
1 |
|
psychotic |
2 |
dominant |
3 |
|
p |
19 |
| screening |
2 |
ecosystem |
1 |
|
compromised |
2 |
attractive |
3 |
|
under |
19 |
| yet |
2 |
astrocytes |
1 |
|
immune |
2 |
evident |
3 |
|
lower |
19 |
| 3 |
2 |
mcs |
1 |
|
fully |
2 |
serious |
3 |
|
low |
19 |
| pcr |
2 |
device |
1 |
|
aware |
2 |
chronic |
2 |
|
virus |
19 |
| landscapes |
2 |
packing |
1 |
|
negative |
2 |
methylated |
2 |
|
single |
19 |
| strategy |
2 |
differentiation |
1 |
|
hyperacetylated |
2 |
droplets |
2 |
|
changes |
19 |
| fractures |
2 |
regimes |
1 |
|
involved |
2 |
accessible |
2 |
|
among |
19 |
| likely |
2 |
necks |
1 |
|
useful |
2 |
pressing |
2 |
|
long |
19 |
| approaches |
2 |
majority |
1 |
|
capable |
2 |
largest |
2 |
|
population |
19 |
| human |
2 |
nanoclusters |
1 |
|
clinically |
2 |
5 |
2 |
|
some |
19 |
| programs |
2 |
studies |
1 |
|
widespread |
2 |
long |
2 |
|
model |
19 |
| constructs |
2 |
cholangiocytes |
1 |
|
visible |
2 |
is |
2 |
|
about |
19 |
| risk |
2 |
hypertension |
1 |
|
wetter |
2 |
widespread |
2 |
|
s |
19 |
| can |
2 |
flow |
1 |
|
commercially |
2 |
crucial |
2 |
|
higher |
18 |
| monitoring |
2 |
reporter |
1 |
|
constrained |
2 |
worldwide |
2 |
|
effective |
18 |
| humans |
2 |
gradually |
1 |
|
standard |
2 |
widely |
2 |
|
cov |
18 |
| n |
2 |
cycles |
1 |
|
pandemic |
2 |
due |
2 |
|
type |
18 |
| virus |
2 |
bodies |
1 |
|
weaker |
2 |
1 |
2 |
|
diseases |
18 |
| food |
2 |
again |
1 |
|
stiffer |
2 |
restricted |
2 |
|
since |
18 |
| carotid |
2 |
niches |
1 |
|
part |
2 |
data |
2 |
|
age |
18 |
| growth |
2 |
pinning |
1 |
|
transcriptionally |
2 |
favorable |
2 |
|
expression |
18 |
| diseases |
2 |
parasites |
1 |
|
chronic |
2 |
susceptible |
2 |
|
molecular |
18 |
| group |
2 |
genomes |
1 |
|
similar |
2 |
useful |
2 |
|
critical |
18 |
| all |
2 |
vessel |
1 |
|
cost |
2 |
integral |
2 |
|
if |
18 |
| cortex |
2 |
seeking |
1 |
|
popular |
2 |
ubiquitous |
2 |
|
study |
18 |
| time |
2 |
geometries |
1 |
|
affected |
2 |
we |
2 |
|
thus |
18 |
| only |
2 |
epidermis |
1 |
|
larger |
2 |
new |
2 |
|
i |
17 |
| local |
2 |
antibodies |
1 |
|
irreversible |
2 |
commonplace |
2 |
|
e |
17 |
| not |
2 |
world |
1 |
|
problematic |
2 |
ill |
2 |
|
then |
17 |
| damage |
2 |
monitoring |
1 |
|
rare |
2 |
deficient |
2 |
|
sars |
17 |
| discovery |
2 |
hcc |
1 |
|
responsive |
2 |
central |
2 |
|
well |
17 |
| systems |
2 |
pvcs |
1 |
|
colonized |
2 |
independent |
2 |
|
interactions |
17 |
| phenotype |
2 |
levels |
1 |
|
entirely |
2 |
interesting |
2 |
|
term |
17 |
| life |
2 |
information |
1 |
|
well |
2 |
growing |
2 |
|
all |
17 |
| novel |
2 |
oxygen |
1 |
|
recently |
2 |
accurate |
2 |
|
evidence |
17 |
| tend |
2 |
first |
1 |
|
aggregated |
2 |
point |
2 |
|
novel |
17 |
| catalysis |
2 |
merely |
1 |
|
oc |
2 |
state |
2 |
|
n |
17 |
| individuals |
2 |
system |
1 |
|
extinct |
2 |
resulting |
2 |
|
infected |
17 |
| mechanism |
2 |
removal |
1 |
|
positive |
1 |
concentrated |
2 |
|
19 |
17 |
| substrate |
2 |
nucleus |
1 |
|
re |
1 |
likely |
2 |
|
two |
17 |
| studies |
2 |
wave |
1 |
|
adipocytes |
1 |
following |
2 |
|
further |
17 |
| diet |
2 |
malaria |
1 |
|
quiescent |
1 |
active |
2 |
|
rate |
17 |
| methods |
2 |
nonetheless |
1 |
|
buried |
1 |
favourable |
2 |
|
only |
17 |
| pathway |
2 |
suddenly |
1 |
|
polarized |
1 |
very |
2 |
|
methods |
17 |
| ai |
2 |
probably |
1 |
|
as |
1 |
urgent |
2 |
|
care |
17 |
| activated |
1 |
poultry |
1 |
|
diffusion |
1 |
only |
2 |
|
respiratory |
17 |
| due |
1 |
podocytes |
1 |
|
enhanced |
1 |
inactivated |
2 |
|
rapid |
16 |
| degrees |
1 |
noncovalent |
1 |
|
lodged |
1 |
via |
2 |
|
dynamics |
16 |
| de |
1 |
viruses |
1 |
|
outstanding |
1 |
authorized |
2 |
|
multiple |
16 |
| rnflt |
1 |
annotations |
1 |
|
fluorescent |
1 |
vulnerable |
2 |
|
gene |
16 |
| effective |
1 |
droughts |
1 |
|
nonlinear |
1 |
0 |
1 |
|
individuals |
16 |
| lvb |
1 |
bands |
1 |
|
intractable |
1 |
stronger |
1 |
|
method |
16 |
| between |
1 |
er |
1 |
|
deposited |
1 |
stable |
1 |
|
major |
16 |
| development |
1 |
biosimilars |
1 |
|
fcs |
1 |
controls |
1 |
|
receptor |
16 |
| power |
1 |
storage |
1 |
|
internalized |
1 |
inevitable |
1 |
|
genome |
16 |
| skin |
1 |
plastics |
1 |
|
entrenched |
1 |
clinically |
1 |
|
covid |
16 |
| l160e |
1 |
since |
1 |
|
abundantly |
1 |
infectious |
1 |
|
recent |
16 |
| particles |
1 |
aunps |
1 |
|
probabilistic |
1 |
recognized |
1 |
|
use |
16 |
| host |
1 |
synapses |
1 |
|
swollen |
1 |
sustained |
1 |
|
coronavirus |
16 |
| since |
1 |
eye |
1 |
|
autoacylated |
1 |
synchronized |
1 |
|
approach |
16 |
| variable |
1 |
colonoids |
1 |
|
proportional |
1 |
antigen |
1 |
|
apparent |
15 |
| folfirinox |
1 |
waveforms |
1 |
|
1 |
1 |
among |
1 |
|
suggest |
15 |
| might |
1 |
glycolysis |
1 |
|
drug |
1 |
stressed |
1 |
|
c |
15 |
| membrane |
1 |
waters |
1 |
|
enzootic |
1 |
barriers |
1 |
|
levels |
15 |
| 25 |
1 |
oct |
1 |
|
intertwined |
1 |
fragile |
1 |
|
dependent |
15 |
| expression |
1 |
likely |
1 |
|
undetectable |
1 |
constrained |
1 |
|
activity |
15 |
| hinges |
1 |
ones |
1 |
|
model |
1 |
scientists |
1 |
|
proteins |
15 |
| in |
1 |
disorder |
1 |
|
misshapen |
1 |
historical |
1 |
|
found |
15 |
| control |
1 |
mode |
1 |
|
heavily |
1 |
predictable |
1 |
|
increases |
15 |
| temperatures |
1 |
training |
1 |
|
parpi |
1 |
integer |
1 |
|
mechanisms |
15 |
| gfp |
1 |
fields |
1 |
|
repressed |
1 |
therapeutic |
1 |
|
infection |
15 |
| snvs |
1 |
flights |
1 |
|
severe |
1 |
filled |
1 |
|
increased |
15 |
| rwe |
1 |
integrity |
1 |
|
silenced |
1 |
reference |
1 |
|
models |
15 |
| elements |
1 |
2 |
1 |
|
treatment |
1 |
hyperproliferative |
1 |
|
effects |
15 |
| stress |
1 |
cell |
1 |
|
public |
1 |
trend |
1 |
|
signaling |
15 |
| until |
1 |
ratio |
1 |
|
richer |
1 |
rare |
1 |
|
b |
15 |
| nmr |
1 |
conformation |
1 |
|
split |
1 |
our |
1 |
|
increasing |
15 |
| limit |
1 |
drugs |
1 |
|
abundant |
1 |
candidates |
1 |
|
do |
15 |
| fisher |
1 |
functionalities |
1 |
|
indistinguishable |
1 |
interest |
1 |
|
including |
15 |
| electricity |
1 |
after |
1 |
|
rapidly |
1 |
larger |
1 |
|
sensitive |
15 |
| heinz |
1 |
other |
1 |
|
turn |
1 |
dysbiotic |
1 |
|
likely |
15 |
| forecasted |
1 |
nucleotides |
1 |
|
overloaded |
1 |
hubs |
1 |
|
life |
14 |
| poised |
1 |
naturally |
1 |
|
significant |
1 |
infrared |
1 |
|
responses |
14 |
| matrix |
1 |
mcg |
1 |
|
phthisical |
1 |
organisms |
1 |
|
system |
14 |
| multimers |
1 |
corals |
1 |
|
vital |
1 |
decorated |
1 |
|
part |
14 |
| america |
1 |
sip |
1 |
|
both |
1 |
strengthened |
1 |
|
primary |
14 |
| plectoneme |
1 |
time |
1 |
|
irreproducible |
1 |
core |
1 |
|
production |
14 |
| linear |
1 |
membrane |
1 |
|
integral |
1 |
health |
1 |
|
result |
14 |
| allergies |
1 |
genome |
1 |
|
wnt |
1 |
highly |
1 |
|
find |
14 |
| enzyme |
1 |
57 |
1 |
|
tethered |
1 |
especially |
1 |
|
food |
14 |
| fluids |
1 |
acids |
1 |
|
effective |
1 |
world |
1 |
|
useful |
14 |
| production |
1 |
memories |
1 |
|
seven |
1 |
later |
1 |
|
particularly |
14 |
| mri |
1 |
flux |
1 |
|
hypermethylated |
1 |
potent |
1 |
|
understanding |
14 |
| shelter |
1 |
cisterns |
1 |
|
clearest |
1 |
center |
1 |
|
rapidly |
14 |
| sectional |
1 |
mitochondria |
1 |
|
unobserved |
1 |
dense |
1 |
|
because |
14 |
| need |
1 |
systems |
1 |
|
immunodominant |
1 |
structured |
1 |
|
different |
14 |
| star3d |
1 |
dependence |
1 |
|
concentrated |
1 |
colonized |
1 |
|
induced |
14 |
| 6 |
1 |
retrieval |
1 |
|
efficient |
1 |
responsive |
1 |
|
efficient |
14 |
| water |
1 |
deposition |
1 |
|
versatile |
1 |
early |
1 |
|
tumor |
14 |
| iecology |
1 |
gamma |
1 |
|
coplanar |
1 |
compared |
1 |
|
risk |
13 |
| problems |
1 |
values |
1 |
|
misfolded |
1 |
obesogenic |
1 |
|
growth |
13 |
| storage |
1 |
rims |
1 |
|
gene |
1 |
permeable |
1 |
|
contrast |
13 |
| load |
1 |
phosphorus |
1 |
|
two |
1 |
now |
1 |
|
like |
13 |
| v4 |
1 |
ins |
1 |
|
transiently |
1 |
significance |
1 |
|
standard |
13 |
| ds |
1 |
haloperidol |
1 |
|
smoother |
1 |
hemophagocytic |
1 |
|
despite |
13 |
| nanomaterials |
1 |
reaction |
1 |
|
crowded |
1 |
oct |
1 |
|
limited |
13 |
| outbreaks |
1 |
norm |
1 |
|
vulnerable |
1 |
while |
1 |
|
active |
13 |
| pscs |
1 |
variants |
1 |
|
practically |
1 |
invisible |
1 |
|
brain |
13 |
| stimuli |
1 |
encapsulation |
1 |
|
directional |
1 |
prototype |
1 |
|
knowledge |
13 |
| boundary |
1 |
glands |
1 |
|
prone |
1 |
sliding |
1 |
|
climate |
13 |
| hospitals |
1 |
tissue |
1 |
|
absorptive |
1 |
practical |
1 |
|
state |
13 |
| harvesting |
1 |
conformations |
1 |
|
porous |
1 |
cross |
1 |
|
function |
13 |
| themselves |
1 |
genomics |
1 |
|
spem |
1 |
coordinated |
1 |
|
analyses |
13 |
| heat |
1 |
function |
1 |
|
critically |
1 |
low |
1 |
|
mutations |
13 |
| fibrils |
1 |
particles |
1 |
|
temporarily |
1 |
regulated |
1 |
|
even |
13 |
| monochromatic |
1 |
proliferation |
1 |
|
lysogenic |
1 |
building |
1 |
|
regions |
13 |
| gangrene |
1 |
allele |
1 |
|
editing |
1 |
tetraploid |
1 |
|
pandemic |
13 |
| regions |
1 |
whole |
1 |
|
obvious |
1 |
nir |
1 |
|
water |
13 |
| infections |
1 |
views |
1 |
|
untrustworthy |
1 |
real |
1 |
|
transmission |
13 |
| solutions |
1 |
basin |
1 |
|
softened |
1 |
this |
1 |
|
better |
13 |
| technology |
1 |
10 |
1 |
|
arrested |
1 |
silencing |
1 |
|
across |
13 |
| understand |
1 |
conversion |
1 |
|
fate |
1 |
prime |
1 |
|
diagnostic |
13 |
| embryos |
1 |
workers |
1 |
|
cataleptic |
1 |
elaborate |
1 |
|
materials |
13 |
| flo1 |
1 |
qty29 |
1 |
|
antibiotic |
1 |
spindle |
1 |
|
microbial |
12 |
| agents |
1 |
9 |
1 |
|
infiltrated |
1 |
asymmetric |
1 |
|
level |
12 |
| text |
1 |
signals |
1 |
|
paramount |
1 |
enablers |
1 |
|
carbon |
12 |
| will |
1 |
microglia |
1 |
|
necessary |
1 |
alternate |
1 |
|
methylation |
12 |
| transmission |
1 |
limitation |
1 |
|
propagative |
1 |
unusable |
1 |
|
become |
12 |
| gallinaceous |
1 |
timing |
1 |
|
long |
1 |
23 |
1 |
|
popular |
12 |
| catalyzed |
1 |
ring |
1 |
|
readily |
1 |
toward |
1 |
|
control |
12 |
| biomodels |
1 |
chromatin |
1 |
|
unresectable |
1 |
tempering |
1 |
|
neurons |
12 |
| snow |
1 |
biostratigraphy |
1 |
|
periodic |
1 |
destabilized |
1 |
|
network |
12 |
| marijuana |
1 |
size |
1 |
|
insulin |
1 |
through |
1 |
|
functional |
12 |
| where |
1 |
uptake |
1 |
|
reversible |
1 |
influential |
1 |
|
relevant |
12 |
| after |
1 |
interactivity |
1 |
|
food |
1 |
type |
1 |
|
environmental |
12 |
| abpsh3 |
1 |
01 |
1 |
|
familiar |
1 |
excitable |
1 |
|
management |
12 |
| reservoir |
1 |
beijinhos |
1 |
|
inhibited |
1 |
pertinent |
1 |
|
presence |
12 |
| checkpoint |
1 |
regions |
1 |
|
transfusion |
1 |
whereas |
1 |
|
environment |
12 |
| stability |
1 |
resources |
1 |
|
phagocytic |
1 |
additions |
1 |
|
provide |
12 |
| spheroids |
1 |
coleorhiza |
1 |
|
later |
1 |
along |
1 |
|
temperature |
12 |
| go |
1 |
coronavirus |
1 |
|
binucleated |
1 |
goal |
1 |
|
10 |
12 |
| system |
1 |
rates |
1 |
|
routine |
1 |
precise |
1 |
|
number |
12 |
| visual |
1 |
isopropanol |
1 |
|
but |
1 |
pre |
1 |
|
immune |
12 |
| tevar |
1 |
trees |
1 |
|
dispensable |
1 |
accepting |
1 |
|
understand |
12 |
| spine |
1 |
odorants |
1 |
|
totipotent |
1 |
quantitative |
1 |
|
sequencing |
12 |
| lca |
1 |
rewards |
1 |
|
irreversibly |
1 |
lived |
1 |
|
powerful |
12 |
| psychiatrist |
1 |
ultimately |
1 |
|
inseparable |
1 |
detectable |
1 |
|
individual |
12 |
| glucosylceramide |
1 |
mediators |
1 |
|
softer |
1 |
materials |
1 |
|
selection |
12 |
| experimental |
1 |
hcws |
1 |
|
reactive |
1 |
57 |
1 |
|
genomes |
12 |
| traps |
1 |
detour |
1 |
|
state |
1 |
liberal |
1 |
|
key |
12 |
| experiment |
1 |
remains |
1 |
|
reinforced |
1 |
viable |
1 |
|
imaging |
12 |
| ehr |
1 |
66 |
1 |
|
health |
1 |
energy |
1 |
|
crucial |
12 |
| bevacizumab |
1 |
4 |
1 |
|
inaccurate |
1 |
ingredients |
1 |
|
related |
12 |
| surface |
1 |
inhibitors |
1 |
|
solid |
1 |
difficult |
1 |
|
public |
12 |
| epithelial |
1 |
issues |
1 |
|
bound |
1 |
clinical |
1 |
|
acute |
12 |
| vesicles |
1 |
rhythm |
1 |
|
significantly |
1 |
hydrophilic |
1 |
|
syndrome |
12 |
| printing |
1 |
technologies |
1 |
|
positively |
1 |
hazardous |
1 |
|
damage |
12 |
| discriminative |
1 |
laboratory |
1 |
|
anticorrelated |
1 |
emerging |
1 |
|
similar |
12 |
| mass |
1 |
on |
1 |
|
earlier |
1 |
ongoing |
1 |
|
hiv |
12 |
| prior |
1 |
structures |
1 |
|
ultra |
1 |
enabling |
1 |
|
following |
12 |
| spectrum |
1 |
apart |
1 |
|
non |
1 |
despite |
1 |
|
95 |
11 |
| momenta |
1 |
regularly |
1 |
|
invaluable |
1 |
electron |
1 |
|
phase |
11 |
| who |
1 |
had |
1 |
|
even |
1 |
disruptive |
1 |
|
design |
11 |
| assay |
1 |
production |
1 |
|
clearly |
1 |
broad |
1 |
|
lipid |
11 |
| structures |
1 |
coupling |
1 |
|
symbionts |
1 |
nc |
1 |
|
local |
11 |
| during |
1 |
fragments |
1 |
|
uninsured |
1 |
readily |
1 |
|
women |
11 |
| magnetic |
1 |
cycling |
1 |
|
looser |
1 |
committed |
1 |
|
free |
11 |
| personnel |
1 |
microbiomes |
1 |
|
synchronized |
1 |
reality |
1 |
|
near |
11 |
| its |
1 |
media |
1 |
|
biofouled |
1 |
nor |
1 |
|
cardiovascular |
11 |
| atl |
1 |
members |
1 |
|
dramatically |
1 |
mandatory |
1 |
|
scale |
11 |
| concept |
1 |
epicardium |
1 |
|
approximately |
1 |
zoonotic |
1 |
|
therapies |
11 |
| recipients |
1 |
spindles |
1 |
|
relatively |
1 |
quiescent |
1 |
|
need |
11 |
| complex |
1 |
coalescent |
1 |
|
functional |
1 |
would |
1 |
|
especially |
11 |
| evolve |
1 |
right |
1 |
|
all |
1 |
will |
1 |
|
tools |
11 |
| phage |
1 |
adaptively |
1 |
|
pronounced |
1 |
engram |
1 |
|
very |
11 |
| if |
1 |
face |
1 |
|
core |
1 |
strongly |
1 |
|
learning |
11 |
| ad |
1 |
events |
1 |
|
unbalanced |
1 |
directed |
1 |
|
so |
11 |
| gs |
1 |
heritability |
1 |
|
time |
1 |
ordered |
1 |
|
cost |
11 |
| materials |
1 |
ryr2 |
1 |
|
dormant |
1 |
professionals |
1 |
|
effect |
11 |
| influences |
1 |
phenotypes |
1 |
|
overt |
1 |
distinct |
1 |
|
established |
11 |
| lineages |
1 |
mags |
1 |
|
oriented |
1 |
physician |
1 |
|
mass |
11 |
| decay |
1 |
depletion |
1 |
|
avidly |
1 |
improved |
1 |
|
children |
11 |
| rat |
1 |
binding |
1 |
|
indefinite |
1 |
reinforced |
1 |
|
cases |
11 |
| antineoplastic |
1 |
testing |
1 |
|
insoluble |
1 |
rapid |
1 |
|
observed |
11 |
| remarkable |
1 |
spleen |
1 |
|
unwieldy |
1 |
endangered |
1 |
|
via |
11 |
| centrioles |
1 |
efficiently |
1 |
|
prevalent |
1 |
intermediate |
1 |
|
increase |
11 |
| mirfps |
1 |
type |
1 |
|
cheaper |
1 |
potential |
1 |
|
approaches |
11 |
| donors |
1 |
layers |
1 |
|
visibly |
1 |
cooperators |
1 |
|
structure |
11 |
| rings |
1 |
strategy |
1 |
|
disadvantageous |
1 |
particular |
1 |
|
mice |
11 |
| song |
1 |
floor |
1 |
|
multipotent |
1 |
upregulated |
1 |
|
compared |
10 |
| masting |
1 |
bias |
1 |
|
viable |
1 |
strange |
1 |
|
sites |
10 |
| we |
1 |
nutrients |
1 |
|
fresher |
1 |
thereby |
1 |
|
transcription |
10 |
| adulthood |
1 |
si |
1 |
|
myopic |
1 |
diverse |
1 |
|
factors |
10 |
| micrornas |
1 |
bronchioles |
1 |
|
deactivated |
1 |
starting |
1 |
|
patterns |
10 |
| rdcs |
1 |
lymph |
1 |
|
altered |
1 |
issue |
1 |
|
role |
10 |
| asps |
1 |
day |
1 |
|
nonsignificant |
1 |
relatively |
1 |
|
plant |
10 |
| endothelial |
1 |
vorticity |
1 |
|
depersulfidated |
1 |
terrestrialised |
1 |
|
surface |
10 |
| entire |
1 |
smurf2 |
1 |
|
senescent |
1 |
separated |
1 |
|
membrane |
10 |
| whom |
1 |
diet |
1 |
|
embedded |
1 |
stereotyped |
1 |
|
widely |
10 |
| amino |
1 |
at |
1 |
|
sick |
1 |
successful |
1 |
|
underlying |
10 |
| seq |
1 |
2e |
1 |
|
effectors |
1 |
effector |
1 |
|
addition |
10 |
| associative |
1 |
distortions |
1 |
|
also |
1 |
shortly |
1 |
|
difficult |
10 |
| hexamer |
1 |
complexes |
1 |
|
first |
1 |
depleted |
1 |
|
whereas |
10 |
| nanps |
1 |
m13 |
1 |
|
misaligned |
1 |
strategies |
1 |
|
activation |
10 |
| gene |
1 |
trap |
1 |
|
severely |
1 |
equal |
1 |
|
suggests |
10 |
| camkii |
1 |
extracellularly |
1 |
|
substantially |
1 |
high |
1 |
|
loss |
10 |
| xas |
1 |
kidneys |
1 |
|
easier |
1 |
too |
1 |
|
stimuli |
10 |
| zcs |
1 |
clusters |
1 |
|
alpha |
1 |
adult |
1 |
|
outcomes |
10 |
| dna |
1 |
transcriptomes |
1 |
|
exhausted |
1 |
may |
1 |
|
alternative |
10 |
| annotation |
1 |
conditions |
1 |
|
source |
1 |
so |
1 |
|
often |
10 |
| traits |
1 |
patients |
1 |
|
central |
1 |
consuming |
1 |
|
resulting |
10 |
| productivity |
1 |
oligos |
1 |
|
seeded |
1 |
last |
1 |
|
functions |
10 |
| on |
1 |
metabolism |
1 |
|
metabolically |
1 |
epidemic |
1 |
|
ms |
10 |
| markets |
1 |
kinases |
1 |
|
bona |
1 |
e |
1 |
|
focus |
10 |
| keyhole |
1 |
arf |
1 |
|
principal |
1 |
pursued |
1 |
|
remains |
10 |
| screams |
1 |
web |
1 |
|
archaic |
1 |
suited |
1 |
|
driven |
10 |
| differences |
1 |
grains |
1 |
|
key |
1 |
marked |
1 |
|
applications |
10 |
| world |
1 |
bacteria |
1 |
|
structured |
1 |
diagnostic |
1 |
|
monitoring |
10 |
| plan |
1 |
wings |
1 |
|
tolerized |
1 |
late |
1 |
|
candidates |
10 |
| field |
1 |
shh |
1 |
|
faster |
1 |
closer |
1 |
|
central |
10 |
| pol |
1 |
subdomains |
1 |
|
exposed |
1 |
throughout |
1 |
|
testing |
10 |
| respective |
1 |
keratins |
1 |
|
reproductively |
1 |
entangled |
1 |
|
performance |
10 |
| red |
1 |
fusion |
1 |
|
lower |
1 |
labor |
1 |
|
interaction |
10 |
| bacterial |
1 |
ser |
1 |
|
enriched |
1 |
progenitors |
1 |
|
challenge |
10 |
| v3 |
1 |
biocircuits |
1 |
|
asymmetrically |
1 |
information |
1 |
|
bacteria |
10 |
| effect |
1 |
consortia |
1 |
|
proteolytically |
1 |
weakening |
1 |
|
initially |
10 |
| free |
1 |
areas |
1 |
|
permissive |
1 |
selective |
1 |
|
several |
10 |
| halides |
1 |
gsk3beta |
1 |
|
worse |
1 |
strong |
1 |
|
field |
10 |
| ligation |
1 |
daas |
1 |
|
obese |
1 |
generating |
1 |
|
point |
10 |
| motions |
1 |
hfd |
1 |
|
spatially |
1 |
tasks |
1 |
|
importance |
10 |
| regulated |
1 |
synthesis |
1 |
|
exciting |
1 |
potentially |
1 |
|
essential |
10 |
| flares |
1 |
pain |
1 |
|
mog |
1 |
object |
1 |
|
experimental |
9 |
| groups |
1 |
strategies |
1 |
|
obsolete |
1 |
discriminable |
1 |
|
negative |
9 |
| minority |
1 |
increasingly |
1 |
|
enmeshed |
1 |
large |
1 |
|
de |
9 |
| images |
1 |
ligand |
1 |
|
greatly |
1 |
an |
1 |
|
properties |
9 |
| exocrine |
1 |
dots |
1 |
|
deaf |
1 |
metabolic |
1 |
|
formation |
9 |
| asyn |
1 |
respiration |
1 |
|
replaced |
1 |
line |
1 |
|
mature |
9 |
| them |
1 |
concurrently |
1 |
|
weakly |
1 |
helical |
1 |
|
current |
9 |
| icus |
1 |
loss |
1 |
|
invasive |
1 |
oligomerize |
1 |
|
onset |
9 |
| zta |
1 |
consistently |
1 |
|
redundant |
1 |
comprehensive |
1 |
|
g |
9 |
| use |
1 |
phosphatases |
1 |
|
edible |
1 |
fide |
1 |
|
transition |
9 |
| aerosol |
1 |
2019 |
1 |
|
aligned |
1 |
diffused |
1 |
|
stress |
9 |
| detection |
1 |
cac |
1 |
|
cd38 |
1 |
it |
1 |
|
binding |
9 |
| used |
1 |
dcs |
1 |
|
refractory |
1 |
investigators |
1 |
|
viruses |
9 |
| aex |
1 |
task |
1 |
|
pressing |
1 |
2 |
1 |
|
regulatory |
9 |
| pigment |
1 |
does |
1 |
|
and |
1 |
challenging |
1 |
|
pregnant |
9 |
| are |
1 |
locus |
1 |
|
relevant |
1 |
alpha |
1 |
|
accessible |
9 |
| political |
1 |
person |
1 |
|
single |
1 |
formidable |
1 |
|
older |
9 |
| cryoem |
1 |
flows |
1 |
|
phenotypically |
1 |
isolated |
1 |
|
science |
9 |
| great |
1 |
metallacycle |
1 |
|
reciprocally |
1 |
using |
1 |
|
pathways |
9 |
| 9 |
1 |
core |
1 |
|
to |
1 |
desirable |
1 |
|
improved |
9 |
| silicon |
1 |
holography |
1 |
|
fatally |
1 |
peh |
1 |
|
therefore |
9 |
| idea |
1 |
lpz |
1 |
|
asynchronous |
1 |
necessity |
1 |
|
size |
9 |
| healthcare |
1 |
herein |
1 |
|
rate |
1 |
inherited |
1 |
|
no |
9 |
| cxcr4 |
1 |
seasons |
1 |
|
extended |
1 |
opportunity |
1 |
|
relative |
9 |
| i |
1 |
tregs |
1 |
|
limited |
1 |
beneficial |
1 |
|
evolution |
9 |
| tendency |
1 |
lattice |
1 |
|
perturbed |
1 |
substantial |
1 |
|
identify |
9 |
| 42 |
1 |
phenomena |
1 |
|
drier |
1 |
ice |
1 |
|
rna |
9 |
| us |
1 |
fundus |
1 |
|
functionally |
1 |
leads |
1 |
|
features |
9 |
| mips |
1 |
substrates |
1 |
|
evident |
1 |
saving |
1 |
|
distinct |
9 |
| coli |
1 |
masks |
1 |
|
atrophic |
1 |
acidified |
1 |
|
structural |
9 |
| whether |
1 |
species |
1 |
|
extremely |
1 |
appreciated |
1 |
|
areas |
9 |
| b |
1 |
firing |
1 |
|
safer |
1 |
user |
1 |
|
work |
9 |
| slope |
1 |
d614g |
1 |
|
electric |
1 |
dysregulated |
1 |
|
mechanism |
9 |
| sleep |
1 |
correlation |
1 |
|
computationally |
1 |
exploratory |
1 |
|
self |
9 |
| adjacent |
1 |
area |
1 |
|
oxidized |
1 |
causes |
1 |
|
14 |
9 |
| lagging |
1 |
thereby |
1 |
|
stationary |
1 |
ab |
1 |
|
issue |
9 |
| calorimetry |
1 |
rris |
1 |
|
restricted |
1 |
pandemic |
1 |
|
strategies |
9 |
| sample |
1 |
materials |
1 |
|
wave |
1 |
reactive |
1 |
|
promising |
9 |
| efficient |
1 |
sample |
1 |
|
controllable |
1 |
easily |
1 |
|
discovery |
9 |
| polymers |
1 |
pathway |
1 |
|
especially |
1 |
promoting |
1 |
|
injury |
9 |
| v |
1 |
ohcs |
1 |
|
hyperexcitable |
1 |
workhorse |
1 |
|
being |
9 |
| nucleus |
1 |
mg |
1 |
|
wic |
1 |
distorted |
1 |
|
states |
9 |
| cycle |
1 |
developments |
1 |
|
active |
1 |
part |
1 |
|
must |
9 |
| cognitive |
1 |
flies |
1 |
|
cross |
1 |
preferable |
1 |
|
thereby |
9 |
| propensity |
1 |
changes |
1 |
|
unpinned |
1 |
basis |
1 |
|
did |
9 |
| thermomechanical |
1 |
pc |
1 |
|
protected |
1 |
existential |
1 |
|
chemical |
9 |
| compounds |
1 |
thalli |
1 |
|
proficient |
1 |
pharmacologically |
1 |
|
techniques |
9 |
| spectroscopy |
1 |
region |
1 |
|
soluble |
1 |
target |
1 |
|
process |
9 |
| cafs |
1 |
issue |
1 |
|
financially |
1 |
accepted |
1 |
|
targeted |
9 |
| 0 |
1 |
ct |
1 |
|
methylated |
1 |
economical |
1 |
|
leads |
9 |
| while |
1 |
conformity |
1 |
|
common |
1 |
essence |
1 |
|
genetic |
8 |
| epr |
1 |
gate |
1 |
|
polymerase |
1 |
inefficacious |
1 |
|
against |
8 |
| mechanosensory |
1 |
end |
1 |
|
connected |
1 |
icos |
1 |
|
ci |
8 |
| participants |
1 |
evidence |
1 |
|
inefficient |
1 |
progressively |
1 |
|
chronic |
8 |
| technologies |
1 |
dislocations |
1 |
|
siloed |
1 |
remain |
1 |
|
past |
8 |
| locations |
1 |
state |
1 |
|
comparable |
1 |
such |
1 |
|
up |
8 |
| networking |
1 |
difficulty |
1 |
|
acquainted |
1 |
some |
1 |
|
derived |
8 |
| zygote |
1 |
ng |
1 |
|
bnabs |
1 |
unique |
1 |
|
networks |
8 |
| issue |
1 |
properties |
1 |
|
therapeutic |
1 |
milestone |
1 |
|
variable |
8 |
| hosting |
1 |
glyrs |
1 |
|
droplet |
1 |
stranded |
1 |
|
now |
8 |
| volatility |
1 |
filaments |
1 |
|
grand |
1 |
unstable |
1 |
|
yet |
8 |
| tomography |
1 |
yet |
1 |
|
redistributed |
1 |
strained |
1 |
|
concentrations |
8 |
| pursue |
1 |
mcscs |
1 |
|
|
|
approximately |
1 |
|
targeting |
8 |
| length |
1 |
video |
1 |
|
|
|
inexpensive |
1 |
|
energy |
8 |
| struggle |
1 |
abundance |
1 |
|
|
|
define |
1 |
|
bacterial |
8 |
| protein |
1 |
antarctica |
1 |
|
|
|
polarized |
1 |
|
last |
8 |
| non |
1 |
like |
1 |
|
|
|
stringent |
1 |
|
predict |
8 |
| autism |
1 |
storms |
1 |
|
|
|
epicenter |
1 |
|
progressively |
8 |
| would |
1 |
sections |
1 |
|
|
|
limited |
1 |
|
until |
8 |
| slower |
1 |
intromission |
1 |
|
|
|
non |
1 |
|
ratio |
8 |
| morphology |
1 |
|
|
|
|
|
educated |
1 |
|
decreased |
8 |
| representations |
1 |
|
|
|
|
|
competent |
1 |
|
worldwide |
8 |
| their |
1 |
|
|
|
|
|
untenable |
1 |
|
period |
8 |
| artefacts |
1 |
|
|
|
|
|
complicated |
1 |
|
composition |
8 |
| bold |
1 |
|
|
|
|
|
field |
1 |
|
cellular |
8 |
| space |
1 |
|
|
|
|
|
intractable |
1 |
|
detection |
8 |
| uio |
1 |
|
|
|
|
|
lipid |
1 |
|
prevent |
8 |
| 95 |
1 |
|
|
|
|
|
abortive |
1 |
|
form |
8 |
| biofluids |
1 |
|
|
|
|
|
reliable |
1 |
|
greater |
8 |
| modeling |
1 |
|
|
|
|
|
vehicle |
1 |
|
exposure |
8 |
| legumains |
1 |
|
|
|
|
|
aware |
1 |
|
significant |
8 |
| ngfr |
1 |
|
|
|
|
|
also |
1 |
|
diagnosis |
8 |
| ge |
1 |
|
|
|
|
|
efficient |
1 |
|
improve |
8 |
| atm |
1 |
|
|
|
|
|
inhibited |
1 |
|
still |
8 |
| surgery |
1 |
|
|
|
|
|
evidenced |
1 |
|
light |
8 |
| designs |
1 |
|
|
|
|
|
random |
1 |
|
previously |
8 |
| asp |
1 |
|
|
|
|
|
linked |
1 |
|
vaccine |
8 |
| engineered |
1 |
|
|
|
|
|
areas |
1 |
|
whole |
8 |
| coherence |
1 |
|
|
|
|
|
device |
1 |
|
ice |
8 |
| comparisons |
1 |
|
|
|
|
|
sophisticated |
1 |
|
various |
8 |
| virology |
1 |
|
|
|
|
|
had |
1 |
|
populations |
8 |
| hiv |
1 |
|
|
|
|
|
organized |
1 |
|
mechanical |
8 |
| increases |
1 |
|
|
|
|
|
remains |
1 |
|
independent |
8 |
| igan |
1 |
|
|
|
|
|
unmet |
1 |
|
sequence |
8 |
| death |
1 |
|
|
|
|
|
feasible |
1 |
|
actin |
8 |
| days |
1 |
|
|
|
|
|
registered |
1 |
|
technology |
8 |
| mantle |
1 |
|
|
|
|
|
uniform |
1 |
|
traditional |
8 |
| deficits |
1 |
|
|
|
|
|
activating |
1 |
|
social |
8 |
| no |
1 |
|
|
|
|
|
first |
1 |
|
reactions |
8 |
| populations |
1 |
|
|
|
|
|
predictive |
1 |
|
ever |
8 |
| interdimer |
1 |
|
|
|
|
|
substrates |
1 |
|
types |
8 |
| alignment |
1 |
|
|
|
|
|
intense |
1 |
|
evolutionary |
8 |
| microplastic |
1 |
|
|
|
|
|
periodically |
1 |
|
2019 |
8 |
| heu |
1 |
|
|
|
|
|
targets |
1 |
|
longer |
8 |
| gas |
1 |
|
|
|
|
|
like |
1 |
|
quantum |
8 |
| cobalt |
1 |
|
|
|
|
|
repressed |
1 |
|
pathway |
8 |
| truffles |
1 |
|
|
|
|
|
cornerstone |
1 |
|
resistance |
8 |
| illness |
1 |
|
|
|
|
|
has |
1 |
|
set |
8 |
| salivary |
1 |
|
|
|
|
|
gold |
1 |
|
impact |
8 |
| aspirations |
1 |
|
|
|
|
|
revolutionizing |
1 |
|
strategy |
8 |
| restorative |
1 |
|
|
|
|
|
|
|
|
rich |
8 |
| ppvi |
1 |
|
|
|
|
|
|
|
|
area |
8 |
| diagnosis |
1 |
|
|
|
|
|
|
|
|
organic |
8 |
| colistin |
1 |
|
|
|
|
|
|
|
|
diversity |
7 |
| bonds |
1 |
|
|
|
|
|
|
|
|
tissue |
7 |
| for |
1 |
|
|
|
|
|
|
|
|
mortality |
7 |
| epidemiology |
1 |
|
|
|
|
|
|
|
|
concern |
7 |
| streams |
1 |
|
|
|
|
|
|
|
|
biomedical |
7 |
| own |
1 |
|
|
|
|
|
|
|
|
ubiquitous |
7 |
| evolved |
1 |
|
|
|
|
|
|
|
|
tissues |
7 |
| syn |
1 |
|
|
|
|
|
|
|
|
m |
7 |
| cigarettes |
1 |
|
|
|
|
|
|
|
|
antigen |
7 |
| tests |
1 |
|
|
|
|
|
|
|
|
site |
7 |
| poorly |
1 |
|
|
|
|
|
|
|
|
showed |
7 |
| pneumonia |
1 |
|
|
|
|
|
|
|
|
host |
7 |
| global |
1 |
|
|
|
|
|
|
|
|
ago |
7 |
| missing |
1 |
|
|
|
|
|
|
|
|
variation |
7 |
| manage |
1 |
|
|
|
|
|
|
|
|
remain |
7 |
| meetings |
1 |
|
|
|
|
|
|
|
|
understood |
7 |
| p |
1 |
|
|
|
|
|
|
|
|
zikv |
7 |
| factor |
1 |
|
|
|
|
|
|
|
|
fluorescence |
7 |
| pandemic |
1 |
|
|
|
|
|
|
|
|
processes |
7 |
| media |
1 |
|
|
|
|
|
|
|
|
world |
7 |
| most |
1 |
|
|
|
|
|
|
|
|
spread |
7 |
| mrd |
1 |
|
|
|
|
|
|
|
|
future |
7 |
| whereabouts |
1 |
|
|
|
|
|
|
|
|
prevalent |
7 |
| deeper |
1 |
|
|
|
|
|
|
|
|
machine |
7 |
| addition |
1 |
|
|
|
|
|
|
|
|
antibodies |
7 |
| dad |
1 |
|
|
|
|
|
|
|
|
countries |
7 |
| care |
1 |
|
|
|
|
|
|
|
|
signal |
7 |
| lake |
1 |
|
|
|
|
|
|
|
|
intensity |
7 |
| yes |
1 |
|
|
|
|
|
|
|
|
responsive |
7 |
| therefore |
1 |
|
|
|
|
|
|
|
|
cross |
7 |
| k |
1 |
|
|
|
|
|
|
|
|
smaller |
7 |
| capabilities |
1 |
|
|
|
|
|
|
|
|
valuable |
7 |
| chain |
1 |
|
|
|
|
|
|
|
|
physical |
7 |
| prediction |
1 |
|
|
|
|
|
|
|
|
trials |
7 |
| dces |
1 |
|
|
|
|
|
|
|
|
demonstrate |
7 |
| marcast |
1 |
|
|
|
|
|
|
|
|
measures |
7 |
| cameroon |
1 |
|
|
|
|
|
|
|
|
outbreaks |
7 |
| did |
1 |
|
|
|
|
|
|
|
|
cognitive |
7 |
| forelimb |
1 |
|
|
|
|
|
|
|
|
larger |
7 |
| through |
1 |
|
|
|
|
|
|
|
|
matter |
7 |
| one |
1 |
|
|
|
|
|
|
|
|
source |
7 |
| transcriptome |
1 |
|
|
|
|
|
|
|
|
marine |
7 |
| response |
1 |
|
|
|
|
|
|
|
|
factor |
7 |
| onward |
1 |
|
|
|
|
|
|
|
|
nm |
7 |
| roaming |
1 |
|
|
|
|
|
|
|
|
organisms |
7 |
| doacs |
1 |
|
|
|
|
|
|
|
|
genomic |
7 |
| embryogenesis |
1 |
|
|
|
|
|
|
|
|
fields |
7 |
| glycans |
1 |
|
|
|
|
|
|
|
|
leading |
7 |
| effector |
1 |
|
|
|
|
|
|
|
|
challenging |
7 |
| hmgl |
1 |
|
|
|
|
|
|
|
|
resolution |
7 |
| progression |
1 |
|
|
|
|
|
|
|
|
either |
7 |
| bigger |
1 |
|
|
|
|
|
|
|
|
late |
7 |
| microscopy |
1 |
|
|
|
|
|
|
|
|
assessment |
7 |
| impact |
1 |
|
|
|
|
|
|
|
|
overall |
7 |
| neuronal |
1 |
|
|
|
|
|
|
|
|
substrate |
7 |
| potentiality |
1 |
|
|
|
|
|
|
|
|
neuronal |
7 |
| spread |
1 |
|
|
|
|
|
|
|
|
dynamic |
7 |
| strikingly |
1 |
|
|
|
|
|
|
|
|
generation |
7 |
| editing |
1 |
|
|
|
|
|
|
|
|
community |
7 |
| asics |
1 |
|
|
|
|
|
|
|
|
16 |
7 |
| metadata |
1 |
|
|
|
|
|
|
|
|
decades |
7 |
| nras |
1 |
|
|
|
|
|
|
|
|
cycle |
7 |
| pics |
1 |
|
|
|
|
|
|
|
|
post |
7 |
| suppression |
1 |
|
|
|
|
|
|
|
|
limiting |
7 |
| olpl |
1 |
|
|
|
|
|
|
|
|
biology |
7 |
| responding |
1 |
|
|
|
|
|
|
|
|
modern |
7 |
| neurogenesis |
1 |
|
|
|
|
|
|
|
|
reaction |
7 |
| what |
1 |
|
|
|
|
|
|
|
|
o |
7 |
| conformations |
1 |
|
|
|
|
|
|
|
|
becomes |
7 |
| perturbative |
1 |
|
|
|
|
|
|
|
|
views |
7 |
| indices |
1 |
|
|
|
|
|
|
|
|
sensitivity |
7 |
| immune |
1 |
|
|
|
|
|
|
|
|
each |
7 |
| cornifrons |
1 |
|
|
|
|
|
|
|
|
profiling |
7 |
| stem |
1 |
|
|
|
|
|
|
|
|
h |
7 |
| instead |
1 |
|
|
|
|
|
|
|
|
d |
7 |
| tyrosine |
1 |
|
|
|
|
|
|
|
|
baseline |
6 |
| pollen |
1 |
|
|
|
|
|
|
|
|
remained |
6 |
| adults |
1 |
|
|
|
|
|
|
|
|
degrees |
6 |
| way |
1 |
|
|
|
|
|
|
|
|
re |
6 |
| decreased |
1 |
|
|
|
|
|
|
|
|
enhanced |
6 |
| gut |
1 |
|
|
|
|
|
|
|
|
environments |
6 |
| based |
1 |
|
|
|
|
|
|
|
|
few |
6 |
| centres |
1 |
|
|
|
|
|
|
|
|
blood |
6 |
| larger |
1 |
|
|
|
|
|
|
|
|
power |
6 |
| early |
1 |
|
|
|
|
|
|
|
|
recognized |
6 |
| drugs |
1 |
|
|
|
|
|
|
|
|
promoting |
6 |
| 0005 |
1 |
|
|
|
|
|
|
|
|
known |
6 |
| oncology |
1 |
|
|
|
|
|
|
|
|
sleep |
6 |
| mediate |
1 |
|
|
|
|
|
|
|
|
competent |
6 |
| include |
1 |
|
|
|
|
|
|
|
|
mouse |
6 |
| synthetic |
1 |
|
|
|
|
|
|
|
|
vivo |
6 |
| microbial |
1 |
|
|
|
|
|
|
|
|
flow |
6 |
| membership |
1 |
|
|
|
|
|
|
|
|
identified |
6 |
| projected |
1 |
|
|
|
|
|
|
|
|
dominant |
6 |
| covered |
1 |
|
|
|
|
|
|
|
|
infections |
6 |
| pel |
1 |
|
|
|
|
|
|
|
|
stage |
6 |
| tolc |
1 |
|
|
|
|
|
|
|
|
rise |
6 |
| genes |
1 |
|
|
|
|
|
|
|
|
advanced |
6 |
| an |
1 |
|
|
|
|
|
|
|
|
potentially |
6 |
| communities |
1 |
|
|
|
|
|
|
|
|
frequent |
6 |
| pollution |
1 |
|
|
|
|
|
|
|
|
findings |
6 |
| iron |
1 |
|
|
|
|
|
|
|
|
tested |
6 |
| gis |
1 |
|
|
|
|
|
|
|
|
requires |
6 |
| cytotoxicity |
1 |
|
|
|
|
|
|
|
|
predicted |
6 |
| peptidoglycan |
1 |
|
|
|
|
|
|
|
|
prevalence |
6 |
| nonrelapsing |
1 |
|
|
|
|
|
|
|
|
containing |
6 |
| centrocytes |
1 |
|
|
|
|
|
|
|
|
behavior |
6 |
| cr1 |
1 |
|
|
|
|
|
|
|
|
terminal |
6 |
| carbon |
1 |
|
|
|
|
|
|
|
|
manner |
6 |
| mitochondrial |
1 |
|
|
|
|
|
|
|
|
targets |
6 |
| enhancer |
1 |
|
|
|
|
|
|
|
|
nature |
6 |
| octahedra |
1 |
|
|
|
|
|
|
|
|
threshold |
6 |
| hearing |
1 |
|
|
|
|
|
|
|
|
significantly |
6 |
| precursors |
1 |
|
|
|
|
|
|
|
|
density |
6 |
| nm |
1 |
|
|
|
|
|
|
|
|
lead |
6 |
| taste |
1 |
|
|
|
|
|
|
|
|
consequently |
6 |
| biofilms |
1 |
|
|
|
|
|
|
|
|
absence |
6 |
| phosphorylated |
1 |
|
|
|
|
|
|
|
|
largest |
6 |
| pores |
1 |
|
|
|
|
|
|
|
|
once |
6 |
| therapy |
1 |
|
|
|
|
|
|
|
|
matrix |
6 |
| inoculants |
1 |
|
|
|
|
|
|
|
|
does |
6 |
| subjectivity |
1 |
|
|
|
|
|
|
|
|
end |
6 |
| compartments |
1 |
|
|
|
|
|
|
|
|
enzyme |
6 |
| msi |
1 |
|
|
|
|
|
|
|
|
20 |
6 |
| both |
1 |
|
|
|
|
|
|
|
|
component |
6 |
| age |
1 |
|
|
|
|
|
|
|
|
interest |
6 |
| langerin |
1 |
|
|
|
|
|
|
|
|
selective |
6 |
| carcinogenicity |
1 |
|
|
|
|
|
|
|
|
agents |
6 |
| nontrivial |
1 |
|
|
|
|
|
|
|
|
hypothesis |
6 |
| modulation |
1 |
|
|
|
|
|
|
|
|
particular |
6 |
| transitioned |
1 |
|
|
|
|
|
|
|
|
structures |
6 |
| reuse |
1 |
|
|
|
|
|
|
|
|
rare |
6 |
| mtor |
1 |
|
|
|
|
|
|
|
|
technologies |
6 |
| trade |
1 |
|
|
|
|
|
|
|
|
costs |
6 |
| taxa |
1 |
|
|
|
|
|
|
|
|
accurate |
6 |
| rhythms |
1 |
|
|
|
|
|
|
|
|
allow |
6 |
| membered |
1 |
|
|
|
|
|
|
|
|
reduced |
6 |
| anoxic |
1 |
|
|
|
|
|
|
|
|
emergence |
6 |
| fluorescence |
1 |
|
|
|
|
|
|
|
|
intensive |
6 |
| v1 |
1 |
|
|
|
|
|
|
|
|
ion |
6 |
| approach |
1 |
|
|
|
|
|
|
|
|
spectrometry |
6 |
| described |
1 |
|
|
|
|
|
|
|
|
spectrum |
6 |
| zebrafish |
1 |
|
|
|
|
|
|
|
|
molecules |
6 |
| perovskite |
1 |
|
|
|
|
|
|
|
|
visual |
6 |
| decades |
1 |
|
|
|
|
|
|
|
|
processing |
6 |
| pleistocene |
1 |
|
|
|
|
|
|
|
|
effector |
6 |
| question |
1 |
|
|
|
|
|
|
|
|
develop |
6 |
| motor |
1 |
|
|
|
|
|
|
|
|
co |
6 |
| crops |
1 |
|
|
|
|
|
|
|
|
fully |
6 |
| face |
1 |
|
|
|
|
|
|
|
|
undergo |
6 |
| mn |
1 |
|
|
|
|
|
|
|
|
death |
6 |
| substitution |
1 |
|
|
|
|
|
|
|
|
patient |
6 |
| metropolitan |
1 |
|
|
|
|
|
|
|
|
stem |
6 |
| intervals |
1 |
|
|
|
|
|
|
|
|
metastatic |
6 |
| mutants |
1 |
|
|
|
|
|
|
|
|
x |
6 |
| exchange |
1 |
|
|
|
|
|
|
|
|
cause |
6 |
| metallic |
1 |
|
|
|
|
|
|
|
|
later |
6 |
| models |
1 |
|
|
|
|
|
|
|
|
united |
6 |
| faded |
1 |
|
|
|
|
|
|
|
|
same |
6 |
| multiplex |
1 |
|
|
|
|
|
|
|
|
antibiotic |
6 |
| brca |
1 |
|
|
|
|
|
|
|
|
threat |
6 |
| regional |
1 |
|
|
|
|
|
|
|
|
vulnerable |
6 |
| rodents |
1 |
|
|
|
|
|
|
|
|
invasive |
6 |
| ihcs |
1 |
|
|
|
|
|
|
|
|
produced |
6 |
| cas9 |
1 |
|
|
|
|
|
|
|
|
chemistry |
6 |
| formation |
1 |
|
|
|
|
|
|
|
|
throughout |
6 |
| work |
1 |
|
|
|
|
|
|
|
|
repair |
6 |
| though |
1 |
|
|
|
|
|
|
|
|
clusters |
6 |
| information |
1 |
|
|
|
|
|
|
|
|
revealed |
6 |
| compositional |
1 |
|
|
|
|
|
|
|
|
vital |
6 |
| srfa |
1 |
|
|
|
|
|
|
|
|
theory |
6 |
| bayesian |
1 |
|
|
|
|
|
|
|
|
feasible |
6 |
| pathogen |
1 |
|
|
|
|
|
|
|
|
quantitative |
6 |
| spring |
1 |
|
|
|
|
|
|
|
|
medicine |
6 |
| tdc |
1 |
|
|
|
|
|
|
|
|
routine |
6 |
| infected |
1 |
|
|
|
|
|
|
|
|
growing |
6 |
| must |
1 |
|
|
|
|
|
|
|
|
signals |
6 |
| immunopathologic |
1 |
|
|
|
|
|
|
|
|
magnetic |
6 |
| factors |
1 |
|
|
|
|
|
|
|
|
neuroscience |
6 |
| bypass |
1 |
|
|
|
|
|
|
|
|
groups |
6 |
| spect |
1 |
|
|
|
|
|
|
|
|
metal |
6 |
| guideline |
1 |
|
|
|
|
|
|
|
|
small |
6 |
| predicted |
1 |
|
|
|
|
|
|
|
|
generate |
6 |
| quantum |
1 |
|
|
|
|
|
|
|
|
nitrogen |
6 |
| cohort |
1 |
|
|
|
|
|
|
|
|
modeling |
6 |
| oligomerization |
1 |
|
|
|
|
|
|
|
|
shifts |
6 |
| activation |
1 |
|
|
|
|
|
|
|
|
poor |
6 |
| feeding |
1 |
|
|
|
|
|
|
|
|
wide |
6 |
| occlusion |
1 |
|
|
|
|
|
|
|
|
present |
6 |
| stores |
1 |
|
|
|
|
|
|
|
|
ecological |
6 |
| mechanisms |
1 |
|
|
|
|
|
|
|
|
pronounced |
6 |
| coconut |
1 |
|
|
|
|
|
|
|
|
electron |
6 |
| lif |
1 |
|
|
|
|
|
|
|
|
variants |
6 |
| other |
1 |
|
|
|
|
|
|
|
|
second |
6 |
| degraders |
1 |
|
|
|
|
|
|
|
|
line |
6 |
| further |
1 |
|
|
|
|
|
|
|
|
task |
6 |
| experimentation |
1 |
|
|
|
|
|
|
|
|
random |
6 |
| scattering |
1 |
|
|
|
|
|
|
|
|
assays |
6 |
| decline |
1 |
|
|
|
|
|
|
|
|
assessed |
6 |
| had |
1 |
|
|
|
|
|
|
|
|
throughput |
6 |
| subjects |
1 |
|
|
|
|
|
|
|
|
synthesis |
6 |
| epigenome |
1 |
|
|
|
|
|
|
|
|
required |
6 |
| t |
1 |
|
|
|
|
|
|
|
|
support |
6 |
| mutant |
1 |
|
|
|
|
|
|
|
|
aspects |
6 |
| foods |
1 |
|
|
|
|
|
|
|
|
phosphorylated |
6 |
| intend |
1 |
|
|
|
|
|
|
|
|
intervention |
6 |
| samples |
1 |
|
|
|
|
|
|
|
|
dysfunctional |
5 |
| others |
1 |
|
|
|
|
|
|
|
|
contribute |
5 |
| around |
1 |
|
|
|
|
|
|
|
|
vs |
5 |
| m2 |
1 |
|
|
|
|
|
|
|
|
above |
5 |
| survival |
1 |
|
|
|
|
|
|
|
|
commonplace |
5 |
| related |
1 |
|
|
|
|
|
|
|
|
simulations |
5 |
| acquired |
1 |
|
|
|
|
|
|
|
|
moderate |
5 |
| remain |
1 |
|
|
|
|
|
|
|
|
prior |
5 |
| bulky |
1 |
|
|
|
|
|
|
|
|
methylated |
5 |
| mrsa |
1 |
|
|
|
|
|
|
|
|
rates |
5 |
| patches |
1 |
|
|
|
|
|
|
|
|
stronger |
5 |
| capital |
1 |
|
|
|
|
|
|
|
|
progression |
5 |
| transitions |
1 |
|
|
|
|
|
|
|
|
distribution |
5 |
| tissue |
1 |
|
|
|
|
|
|
|
|
group |
5 |
| state |
1 |
|
|
|
|
|
|
|
|
bone |
5 |
| aerosols |
1 |
|
|
|
|
|
|
|
|
mesenchymal |
5 |
| repetitive |
1 |
|
|
|
|
|
|
|
|
pathogenic |
5 |
| secretions |
1 |
|
|
|
|
|
|
|
|
commonly |
5 |
| reserves |
1 |
|
|
|
|
|
|
|
|
reveal |
5 |
| deportation |
1 |
|
|
|
|
|
|
|
|
infectious |
5 |
| intelligence |
1 |
|
|
|
|
|
|
|
|
breast |
5 |
| behaviours |
1 |
|
|
|
|
|
|
|
|
prostate |
5 |
|
|
|
|
|
|
|
|
|
|
temperatures |
5 |
|
|
|
|
|
|
|
|
|
|
sustained |
5 |
|
|
|
|
|
|
|
|
|
|
robust |
5 |
|
|
|
|
|
|
|
|
|
|
inflammatory |
5 |
|
|
|
|
|
|
|
|
|
|
additional |
5 |
|
|
|
|
|
|
|
|
|
|
interface |
5 |
|
|
|
|
|
|
|
|
|
|
measurements |
5 |
|
|
|
|
|
|
|
|
|
|
spatial |
5 |
|
|
|
|
|
|
|
|
|
|
particles |
5 |
|
|
|
|
|
|
|
|
|
|
60 |
5 |
|
|
|
|
|
|
|
|
|
|
pattern |
5 |
|
|
|
|
|
|
|
|
|
|
landscape |
5 |
|
|
|
|
|
|
|
|
|
|
poorly |
5 |
|
|
|
|
|
|
|
|
|
|
subsequently |
5 |
|
|
|
|
|
|
|
|
|
|
substrates |
5 |
|
|
|
|
|
|
|
|
|
|
na |
5 |
|
|
|
|
|
|
|
|
|
|
ligand |
5 |
|
|
|
|
|
|
|
|
|
|
reported |
5 |
|
|
|
|
|
|
|
|
|
|
constrained |
5 |
|
|
|
|
|
|
|
|
|
|
able |
5 |
|
|
|
|
|
|
|
|
|
|
core |
5 |
|
|
|
|
|
|
|
|
|
|
scientists |
5 |
|
|
|
|
|
|
|
|
|
|
unstable |
5 |
|
|
|
|
|
|
|
|
|
|
acids |
5 |
|
|
|
|
|
|
|
|
|
|
real |
5 |
|
|
|
|
|
|
|
|
|
|
respond |
5 |
|
|
|
|
|
|
|
|
|
|
chromatin |
5 |
|
|
|
|
|
|
|
|
|
|
shows |
5 |
|
|
|
|
|
|
|
|
|
|
heat |
5 |
|
|
|
|
|
|
|
|
|
|
building |
5 |
|
|
|
|
|
|
|
|
|
|
stimulus |
5 |
|
|
|
|
|
|
|
|
|
|
k |
5 |
|
|
|
|
|
|
|
|
|
|
generated |
5 |
|
|
|
|
|
|
|
|
|
|
prominent |
5 |
|
|
|
|
|
|
|
|
|
|
cardiac |
5 |
|
|
|
|
|
|
|
|
|
|
reference |
5 |
|
|
|
|
|
|
|
|
|
|
assembly |
5 |
|
|
|
|
|
|
|
|
|
|
13 |
5 |
|
|
|
|
|
|
|
|
|
|
nucleic |
5 |
|
|
|
|
|
|
|
|
|
|
consistent |
5 |
|
|
|
|
|
|
|
|
|
|
unclear |
5 |
|
|
|
|
|
|
|
|
|
|
safety |
5 |
|
|
|
|
|
|
|
|
|
|
validation |
5 |
|
|
|
|
|
|
|
|
|
|
review |
5 |
|
|
|
|
|
|
|
|
|
|
inhibition |
5 |
|
|
|
|
|
|
|
|
|
|
natural |
5 |
|
|
|
|
|
|
|
|
|
|
viral |
5 |
|
|
|
|
|
|
|
|
|
|
pathologies |
5 |
|
|
|
|
|
|
|
|
|
|
little |
5 |
|
|
|
|
|
|
|
|
|
|
100 |
5 |
|
|
|
|
|
|
|
|
|
|
total |
5 |
|
|
|
|
|
|
|
|
|
|
caused |
5 |
|
|
|
|
|
|
|
|
|
|
abeta |
5 |
|
|
|
|
|
|
|
|
|
|
generating |
5 |
|
|
|
|
|
|
|
|
|
|
epithelial |
5 |
|
|
|
|
|
|
|
|
|
|
regulated |
5 |
|
|
|
|
|
|
|
|
|
|
iii |
5 |
|
|
|
|
|
|
|
|
|
|
layers |
5 |
|
|
|
|
|
|
|
|
|
|
test |
5 |
|
|
|
|
|
|
|
|
|
|
prevention |
5 |
|
|
|
|
|
|
|
|
|
|
introduction |
5 |
|
|
|
|
|
|
|
|
|
|
great |
5 |
|
|
|
|
|
|
|
|
|
|
direct |
5 |
|
|
|
|
|
|
|
|
|
|
secondary |
5 |
|
|
|
|
|
|
|
|
|
|
occurs |
5 |
|
|
|
|
|
|
|
|
|
|
along |
5 |
|
|
|
|
|
|
|
|
|
|
identifying |
5 |
|
|
|
|
|
|
|
|
|
|
technique |
5 |
|
|
|
|
|
|
|
|
|
|
tumors |
5 |
|
|
|
|
|
|
|
|
|
|
pathogens |
5 |
|
|
|
|
|
|
|
|
|
|
enabling |
5 |
|
|
|
|
|
|
|
|
|
|
phenotypes |
5 |
|
|
|
|
|
|
|
|
|
|
slow |
5 |
|
|
|
|
|
|
|
|
|
|
given |
5 |
|
|
|
|
|
|
|
|
|
|
consider |
5 |
|
|
|
|
|
|
|
|
|
|
potent |
5 |
|
|
|
|
|
|
|
|
|
|
center |
5 |
|
|
|
|
|
|
|
|
|
|
next |
5 |
|
|
|
|
|
|
|
|
|
|
mutant |
5 |
|
|
|
|
|
|
|
|
|
|
memory |
5 |
|
|
|
|
|
|
|
|
|
|
emission |
5 |
|
|
|
|
|
|
|
|
|
|
ongoing |
5 |
|
|
|
|
|
|
|
|
|
|
surgical |
5 |
|
|
|
|
|
|
|
|
|
|
evaluate |
5 |
|
|
|
|
|
|
|
|
|
|
liver |
5 |
|
|
|
|
|
|
|
|
|
|
burst |
5 |
|
|
|
|
|
|
|
|
|
|
cortex |
5 |
|
|
|
|
|
|
|
|
|
|
pathogenesis |
5 |
|
|
|
|
|
|
|
|
|
|
medical |
5 |
|
|
|
|
|
|
|
|
|
|
transport |
5 |
|
|
|
|
|
|
|
|
|
|
massive |
5 |
|
|
|
|
|
|
|
|
|
|
precision |
5 |
|
|
|
|
|
|
|
|
|
|
out |
5 |
|
|
|
|
|
|
|
|
|
|
fixed |
5 |
|
|
|
|
|
|
|
|
|
|
coupling |
5 |
|
|
|
|
|
|
|
|
|
|
efficiency |
5 |
|
|
|
|
|
|
|
|
|
|
space |
5 |
|
|
|
|
|
|
|
|
|
|
division |
5 |
|
|
|
|
|
|
|
|
|
|
way |
5 |
|
|
|
|
|
|
|
|
|
|
temporal |
5 |
|
|
|
|
|
|
|
|
|
|
traits |
5 |
|
|
|
|
|
|
|
|
|
|
reactive |
5 |
|
|
|
|
|
|
|
|
|
|
decay |
5 |
|
|
|
|
|
|
|
|
|
|
offer |
5 |
|
|
|
|
|
|
|
|
|
|
limitation |
5 |
|
|
|
|
|
|
|
|
|
|
aromatic |
5 |
|
|
|
|
|
|
|
|
|
|
disorders |
5 |
|
|
|
|
|
|
|
|
|
|
chain |
5 |
|
|
|
|
|
|
|
|
|
|
screening |
5 |
|
|
|
|
|
|
|
|
|
|
programs |
5 |
|
|
|
|
|
|
|
|
|
|
allowing |
5 |
|
|
|
|
|
|
|
|
|
|
nanoparticles |
5 |
|
|
|
|
|
|
|
|
|
|
ser |
5 |
|
|
|
|
|
|
|
|
|
|
r |
5 |
|
|
|
|
|
|
|
|
|
|
electronic |
5 |
|
|
|
|
|
|
|
|
|
|
value |
5 |
|
|
|
|
|
|
|
|
|
|
practice |
5 |
|
|
|
|
|
|
|
|
|
|
strain |
5 |
|
|
|
|
|
|
|
|
|
|
ifn |
5 |
|
|
|
|
|
|
|
|
|
|
communication |
5 |
|
|
|
|
|
|
|
|
|
|
humans |
5 |
|
|
|
|
|
|
|
|
|
|
trends |
5 |
|
|
|
|
|
|
|
|
|
|
suggesting |
5 |
|
|
|
|
|
|
|
|
|
|
capable |
5 |
|
|
|
|
|
|
|
|
|
|
li |
5 |
|
|
|
|
|
|
|
|
|
|
compounds |
5 |
|
|
|
|
|
|
|
|
|
|
healthcare |
5 |
|
|
|
|
|
|
|
|
|
|
regulation |
5 |
|
|
|
|
|
|
|
|
|
|
computational |
5 |
|
|
|
|
|
|
|
|
|
|
forms |
5 |
|
|
|
|
|
|
|
|
|
|
beneficial |
5 |
|
|
|
|
|
|
|
|
|
|
gut |
5 |
|
|
|
|
|
|
|
|
|
|
datasets |
5 |
|
|
|
|
|
|
|
|
|
|
analytical |
5 |
|
|
|
|
|
|
|
|
|
|
polymers |
5 |
|
|
|
|
|
|
|
|
|
|
emerging |
5 |
|
|
|
|
|
|
|
|
|
|
select |
5 |
|
|
|
|
|
|
|
|
|
|
sample |
5 |
|
|
|
|
|
|
|
|
|
|
decline |
5 |
|
|
|
|
|
|
|
|
|
|
multi |
5 |
|
|
|
|
|
|
|
|
|
|
question |
5 |
|
|
|
|
|
|
|
|
|
|
soil |
5 |
|
|
|
|
|
|
|
|
|
|
practices |
5 |
|
|
|
|
|
|
|
|
|
|
diverse |
5 |
|
|
|
|
|
|
|
|
|
|
deuterium |
5 |
|
|
|
|
|
|
|
|
|
|
expected |
5 |
|
|
|
|
|
|
|
|
|
|
alpha |
5 |
|
|
|
|
|
|
|
|
|
|
mid |
5 |
|
|
|
|
|
|
|
|
|
|
precursors |
5 |
|
|
|
|
|
|
|
|
|
|
inactivated |
5 |
|
|
|
|
|
|
|
|
|
|
around |
5 |
|
|
|
|
|
|
|
|
|
|
what |
5 |
|
|
|
|
|
|
|
|
|
|
arctic |
5 |
|
|
|
|
|
|
|
|
|
|
akt |
5 |
|
|
|
|
|
|
|
|
|
|
far |
4 |
|
|
|
|
|
|
|
|
|
|
cytokine |
4 |
|
|
|
|
|
|
|
|
|
|
positive |
4 |
|
|
|
|
|
|
|
|
|
|
01 |
4 |
|
|
|
|
|
|
|
|
|
|
inflammation |
4 |
|
|
|
|
|
|
|
|
|
|
hand |
4 |
|
|
|
|
|
|
|
|
|
|
bound |
4 |
|
|
|
|
|
|
|
|
|
|
difference |
4 |
|
|
|
|
|
|
|
|
|
|
significance |
4 |
|
|
|
|
|
|
|
|
|
|
red |
4 |
|
|
|
|
|
|
|
|
|
|
investigations |
4 |
|
|
|
|
|
|
|
|
|
|
cortical |
4 |
|
|
|
|
|
|
|
|
|
|
stable |
4 |
|
|
|
|
|
|
|
|
|
|
differentiation |
4 |
|
|
|
|
|
|
|
|
|
|
quiescent |
4 |
|
|
|
|
|
|
|
|
|
|
functionally |
4 |
|
|
|
|
|
|
|
|
|
|
clinically |
4 |
|
|
|
|
|
|
|
|
|
|
winter |
4 |
|
|
|
|
|
|
|
|
|
|
2016 |
4 |
|
|
|
|
|
|
|
|
|
|
led |
4 |
|
|
|
|
|
|
|
|
|
|
90 |
4 |
|
|
|
|
|
|
|
|
|
|
spring |
4 |
|
|
|
|
|
|
|
|
|
|
comparison |
4 |
|
|
|
|
|
|
|
|
|
|
unknown |
4 |
|
|
|
|
|
|
|
|
|
|
hence |
4 |
|
|
|
|
|
|
|
|
|
|
hil |
4 |
|
|
|
|
|
|
|
|
|
|
formed |
4 |
|
|
|
|
|
|
|
|
|
|
demonstrated |
4 |
|
|
|
|
|
|
|
|
|
|
applied |
4 |
|
|
|
|
|
|
|
|
|
|
droplets |
4 |
|
|
|
|
|
|
|
|
|
|
exhibits |
4 |
|
|
|
|
|
|
|
|
|
|
temperate |
4 |
|
|
|
|
|
|
|
|
|
|
rather |
4 |
|
|
|
|
|
|
|
|
|
|
healthy |
4 |
|
|
|
|
|
|
|
|
|
|
morphology |
4 |
|
|
|
|
|
|
|
|
|
|
disrupted |
4 |
|
|
|
|
|
|
|
|
|
|
precipitation |
4 |
|
|
|
|
|
|
|
|
|
|
integral |
4 |
|
|
|
|
|
|
|
|
|
|
episodes |
4 |
|
|
|
|
|
|
|
|
|
|
accessibility |
4 |
|
|
|
|
|
|
|
|
|
|
modulated |
4 |
|
|
|
|
|
|
|
|
|
|
25 |
4 |
|
|
|
|
|
|
|
|
|
|
obesity |
4 |
|
|
|
|
|
|
|
|
|
|
goal |
4 |
|
|
|
|
|
|
|
|
|
|
training |
4 |
|
|
|
|
|
|
|
|
|
|
communities |
4 |
|
|
|
|
|
|
|
|
|
|
fluorescent |
4 |
|
|
|
|
|
|
|
|
|
|
denv |
4 |
|
|
|
|
|
|
|
|
|
|
vitro |
4 |
|
|
|
|
|
|
|
|
|
|
mammalian |
4 |
|
|
|
|
|
|
|
|
|
|
needs |
4 |
|
|
|
|
|
|
|
|
|
|
developing |
4 |
|
|
|
|
|
|
|
|
|
|
pre |
4 |
|
|
|
|
|
|
|
|
|
|
existing |
4 |
|
|
|
|
|
|
|
|
|
|
fascicle |
4 |
|
|
|
|
|
|
|
|
|
|
gear |
4 |
|
|
|
|
|
|
|
|
|
|
side |
4 |
|
|
|
|
|
|
|
|
|
|
accepting |
4 |
|
|
|
|
|
|
|
|
|
|
limit |
4 |
|
|
|
|
|
|
|
|
|
|
driving |
4 |
|
|
|
|
|
|
|
|
|
|
differential |
4 |
|
|
|
|
|
|
|
|
|
|
electricity |
4 |
|
|
|
|
|
|
|
|
|
|
sources |
4 |
|
|
|
|
|
|
|
|
|
|
described |
4 |
|
|
|
|
|
|
|
|
|
|
alterations |
4 |
|
|
|
|
|
|
|
|
|
|
providing |
4 |
|
|
|
|
|
|
|
|
|
|
microenvironment |
4 |
|
|
|
|
|
|
|
|
|
|
circulating |
4 |
|
|
|
|
|
|
|
|
|
|
preventing |
4 |
|
|
|
|
|
|
|
|
|
|
forecasted |
4 |
|
|
|
|
|
|
|
|
|
|
economy |
4 |
|
|
|
|
|
|
|
|
|
|
restricted |
4 |
|
|
|
|
|
|
|
|
|
|
main |
4 |
|
|
|
|
|
|
|
|
|
|
extracellular |
4 |
|
|
|
|
|
|
|
|
|
|
necessary |
4 |
|
|
|
|
|
|
|
|
|
|
enhance |
4 |
|
|
|
|
|
|
|
|
|
|
birth |
4 |
|
|
|
|
|
|
|
|
|
|
newly |
4 |
|
|
|
|
|
|
|
|
|
|
force |
4 |
|
|
|
|
|
|
|
|
|
|
intense |
4 |
|
|
|
|
|
|
|
|
|
|
complexity |
4 |
|
|
|
|
|
|
|
|
|
|
linear |
4 |
|
|
|
|
|
|
|
|
|
|
much |
4 |
|
|
|
|
|
|
|
|
|
|
continues |
4 |
|
|
|
|
|
|
|
|
|
|
defined |
4 |
|
|
|
|
|
|
|
|
|
|
preferred |
4 |
|
|
|
|
|
|
|
|
|
|
largely |
4 |
|
|
|
|
|
|
|
|
|
|
efficacy |
4 |
|
|
|
|
|
|
|
|
|
|
3d |
4 |
|
|
|
|
|
|
|
|
|
|
accuracy |
4 |
|
|
|
|
|
|
|
|
|
|
anti |
4 |
|
|
|
|
|
|
|
|
|
|
il |
4 |
|
|
|
|
|
|
|
|
|
|
12 |
4 |
|
|
|
|
|
|
|
|
|
|
23 |
4 |
|
|
|
|
|
|
|
|
|
|
controlling |
4 |
|
|
|
|
|
|
|
|
|
|
considered |
4 |
|
|
|
|
|
|
|
|
|
|
initial |
4 |
|
|
|
|
|
|
|
|
|
|
resource |
4 |
|
|
|
|
|
|
|
|
|
|
living |
4 |
|
|
|
|
|
|
|
|
|
|
decade |
4 |
|
|
|
|
|
|
|
|
|
|
gain |
4 |
|
|
|
|
|
|
|
|
|
|
diagnostics |
4 |
|
|
|
|
|
|
|
|
|
|
events |
4 |
|
|
|
|
|
|
|
|
|
|
v4 |
4 |
|
|
|
|
|
|
|
|
|
|
capacity |
4 |
|
|
|
|
|
|
|
|
|
|
effectiveness |
4 |
|
|
|
|
|
|
|
|
|
|
ability |
4 |
|
|
|
|
|
|
|
|
|
|
though |
4 |
|
|
|
|
|
|
|
|
|
|
express |
4 |
|
|
|
|
|
|
|
|
|
|
acid |
4 |
|
|
|
|
|
|
|
|
|
|
subsets |
4 |
|
|
|
|
|
|
|
|
|
|
action |
4 |
|
|
|
|
|
|
|
|
|
|
oxygen |
4 |
|
|
|
|
|
|
|
|
|
|
lineage |
4 |
|
|
|
|
|
|
|
|
|
|
algorithms |
4 |
|
|
|
|
|
|
|
|
|
|
animal |
4 |
|
|
|
|
|
|
|
|
|
|
correlation |
4 |
|
|
|
|
|
|
|
|
|
|
mm |
4 |
|
|
|
|
|
|
|
|
|
|
ph |
4 |
|
|
|
|
|
|
|
|
|
|
shown |
4 |
|
|
|
|
|
|
|
|
|
|
surgery |
4 |
|
|
|
|
|
|
|
|
|
|
performed |
4 |
|
|
|
|
|
|
|
|
|
|
gas |
4 |
|
|
|
|
|
|
|
|
|
|
muscle |
4 |
|
|
|
|
|
|
|
|
|
|
coastal |
4 |
|
|
|
|
|
|
|
|
|
|
frequency |
4 |
|
|
|
|
|
|
|
|
|
|
lost |
4 |
|
|
|
|
|
|
|
|
|
|
niche |
4 |
|
|
|
|
|
|
|
|
|
|
linked |
4 |
|
|
|
|
|
|
|
|
|
|
widespread |
4 |
|
|
|
|
|
|
|
|
|
|
ligands |
4 |
|
|
|
|
|
|
|
|
|
|
europe |
4 |
|
|
|
|
|
|
|
|
|
|
adapted |
4 |
|
|
|
|
|
|
|
|
|
|
associations |
4 |
|
|
|
|
|
|
|
|
|
|
reducing |
4 |
|
|
|
|
|
|
|
|
|
|
catalytic |
4 |
|
|
|
|
|
|
|
|
|
|
emerged |
4 |
|
|
|
|
|
|
|
|
|
|
atomic |
4 |
|
|
|
|
|
|
|
|
|
|
complexes |
4 |
|
|
|
|
|
|
|
|
|
|
subsequent |
4 |
|
|
|
|
|
|
|
|
|
|
provides |
4 |
|
|
|
|
|
|
|
|
|
|
framework |
4 |
|
|
|
|
|
|
|
|
|
|
myosin |
4 |
|
|
|
|
|
|
|
|
|
|
drugs |
4 |
|
|
|
|
|
|
|
|
|
|
longevity |
4 |
|
|
|
|
|
|
|
|
|
|
outbreak |
4 |
|
|
|
|
|
|
|
|
|
|
without |
4 |
|
|
|
|
|
|
|
|
|
|
mediated |
4 |
|
|
|
|
|
|
|
|
|
|
irreversible |
4 |
|
|
|
|
|
|
|
|
|
|
equilibrium |
4 |
|
|
|
|
|
|
|
|
|
|
thermally |
4 |
|
|
|
|
|
|
|
|
|
|
day |
4 |
|
|
|
|
|
|
|
|
|
|
image |
4 |
|
|
|
|
|
|
|
|
|
|
identity |
4 |
|
|
|
|
|
|
|
|
|
|
neural |
4 |
|
|
|
|
|
|
|
|
|
|
v |
4 |
|
|
|
|
|
|
|
|
|
|
tend |
4 |
|
|
|
|
|
|
|
|
|
|
months |
4 |
|
|
|
|
|
|
|
|
|
|
year |
4 |
|
|
|
|
|
|
|
|
|
|
treated |
4 |
|
|
|
|
|
|
|
|
|
|
substantial |
4 |
|
|
|
|
|
|
|
|
|
|
macrophages |
4 |
|
|
|
|
|
|
|
|
|
|
developed |
4 |
|
|
|
|
|
|
|
|
|
|
option |
4 |
|
|
|
|
|
|
|
|
|
|
waters |
4 |
|
|
|
|
|
|
|
|
|
|
disorder |
4 |
|
|
|
|
|
|
|
|
|
|
anticoagulation |
4 |
|
|
|
|
|
|
|
|
|
|
ill |
4 |
|
|
|
|
|
|
|
|
|
|
report |
4 |
|
|
|
|
|
|
|
|
|
|
phenotype |
4 |
|
|
|
|
|
|
|
|
|
|
assay |
4 |
|
|
|
|
|
|
|
|
|
|
indicate |
4 |
|
|
|
|
|
|
|
|
|
|
reward |
4 |
|
|
|
|
|
|
|
|
|
|
participants |
4 |
|
|
|
|
|
|
|
|
|
|
laboratory |
4 |
|
|
|
|
|
|
|
|
|
|
took |
4 |
|
|
|
|
|
|
|
|
|
|
face |
4 |
|
|
|
|
|
|
|
|
|
|
compromised |
4 |
|
|
|
|
|
|
|
|
|
|
region |
4 |
|
|
|
|
|
|
|
|
|
|
live |
4 |
|
|
|
|
|
|
|
|
|
|
challenges |
4 |
|
|
|
|
|
|
|
|
|
|
concept |
4 |
|
|
|
|
|
|
|
|
|
|
protected |
4 |
|
|
|
|
|
|
|
|
|
|
oxidation |
4 |
|
|
|
|
|
|
|
|
|
|
readily |
4 |
|
|
|
|
|
|
|
|
|
|
capture |
4 |
|
|
|
|
|
|
|
|
|
|
abundance |
4 |
|
|
|
|
|
|
|
|
|
|
anthropogenic |
4 |
|
|
|
|
|
|
|
|
|
|
experiments |
4 |
|
|
|
|
|
|
|
|
|
|
15 |
4 |
|
|
|
|
|
|
|
|
|
|
trapped |
4 |
|
|
|
|
|
|
|
|
|
|
young |
4 |
|
|
|
|
|
|
|
|
|
|
substitution |
4 |
|
|
|
|
|
|
|
|
|
|
asymmetric |
4 |
|
|
|
|
|
|
|
|
|
|
settings |
4 |
|
|
|
|
|
|
|
|
|
|
furthermore |
4 |
|
|
|
|
|
|
|
|
|
|
cancers |
4 |
|
|
|
|
|
|
|
|
|
|
exposed |
4 |
|
|
|
|
|
|
|
|
|
|
residual |
4 |
|
|
|
|
|
|
|
|
|
|
subset |
4 |
|
|
|
|
|
|
|
|
|
|
experience |
4 |
|
|
|
|
|
|
|
|
|
|
hair |
4 |
|
|
|
|
|
|
|
|
|
|
inhibitors |
4 |
|
|
|
|
|
|
|
|
|
|
liquid |
4 |
|
|
|
|
|
|
|
|
|
|
phosphorylation |
4 |
|
|
|
|
|
|
|
|
|
|
indispensable |
4 |
|
|
|
|
|
|
|
|
|
|
mitochondrial |
4 |
|
|
|
|
|
|
|
|
|
|
conservation |
4 |
|
|
|
|
|
|
|
|
|
|
engineering |
4 |
|
|
|
|
|
|
|
|
|
|
quality |
4 |
|
|
|
|
|
|
|
|
|
|
investigating |
4 |
|
|
|
|
|
|
|
|
|
|
detectable |
4 |
|
|
|
|
|
|
|
|
|
|
idea |
4 |
|
|
|
|
|
|
|
|
|
|
crispr |
4 |
|
|
|
|
|
|
|
|
|
|
editing |
4 |
|
|
|
|
|
|
|
|
|
|
deficient |
4 |
|
|
|
|
|
|
|
|
|
|
microscopy |
4 |
|
|
|
|
|
|
|
|
|
|
uniform |
4 |
|
|
|
|
|
|
|
|
|
|
procedures |
4 |
|
|
|
|
|
|
|
|
|
|
normal |
4 |
|
|
|
|
|
|
|
|
|
|
pharmaceutical |
4 |
|
|
|
|
|
|
|
|
|
|
century |
4 |
|
|
|
|
|
|
|
|
|
|
catalysis |
4 |
|
|
|
|
|
|
|
|
|
|
require |
4 |
|
|
|
|
|
|
|
|
|
|
images |
4 |
|
|
|
|
|
|
|
|
|
|
eyes |
4 |
|
|
|
|
|
|
|
|
|
|
sensing |
4 |
|
|
|
|
|
|
|
|
|
|
prediction |
4 |
|
|
|
|
|
|
|
|
|
|
ultimately |
4 |
|
|
|
|
|
|
|
|
|
|
shared |
4 |
|
|
|
|
|
|
|
|
|
|
producing |
4 |
|
|
|
|
|
|
|
|
|
|
students |
4 |
|
|
|
|
|
|
|
|
|
|
versus |
4 |
|
|
|
|
|
|
|
|
|
|
30 |
4 |
|
|
|
|
|
|
|
|
|
|
coupled |
4 |
|
|
|
|
|
|
|
|
|
|
adoption |
4 |
|
|
|
|
|
|
|
|
|
|
inhibited |
4 |
|
|
|
|
|
|
|
|
|
|
threats |
4 |
|
|
|
|
|
|
|
|
|
|
50 |
4 |
|
|
|
|
|
|
|
|
|
|
amount |
4 |
|
|
|
|
|
|
|
|
|
|
depleted |
4 |
|
|
|
|
|
|
|
|
|
|
broad |
4 |
|
|
|
|
|
|
|
|
|
|
era |
4 |
|
|
|
|
|
|
|
|
|
|
activities |
4 |
|
|
|
|
|
|
|
|
|
|
variability |
4 |
|
|
|
|
|
|
|
|
|
|
off |
4 |
|
|
|
|
|
|
|
|
|
|
carotid |
4 |
|
|
|
|
|
|
|
|
|
|
artery |
4 |
|
|
|
|
|
|
|
|
|
|
stiffer |
4 |
|
|
|
|
|
|
|
|
|
|
men |
4 |
|
|
|
|
|
|
|
|
|
|
art |
4 |
|
|
|
|
|
|
|
|
|
|
breeding |
4 |
|
|
|
|
|
|
|
|
|
|
vaccinated |
4 |
|
|
|
|
|
|
|
|
|
|
determine |
4 |
|
|
|
|
|
|
|
|
|
|
optimal |
4 |
|
|
|
|
|
|
|
|
|
|
length |
4 |
|
|
|
|
|
|
|
|
|
|
she |
4 |
|
|
|
|
|
|
|
|
|
|
solid |
4 |
|
|
|
|
|
|
|
|
|
|
regional |
4 |
|
|
|
|
|
|
|
|
|
|
correlated |
4 |
|
|
|
|
|
|
|
|
|
|
inputs |
4 |
|
|
|
|
|
|
|
|
|
|
adults |
4 |
|
|
|
|
|
|
|
|
|
|
finally |
4 |
|
|
|
|
|
|
|
|
|
|
evident |
4 |
|
|
|
|
|
|
|
|
|
|
pain |
4 |
|
|
|
|
|
|
|
|
|
|
diet |
4 |
|
|
|
|
|
|
|
|
|
|
recovery |
4 |
|
|
|
|
|
|
|
|
|
|
domains |
4 |
|
|
|
|
|
|
|
|
|
|
foods |
4 |
|
|
|
|
|
|
|
|
|
|
exciting |
4 |
|
|
|
|
|
|
|
|
|
|
vaccination |
4 |
|
|
|
|
|
|
|
|
|
|
trade |
4 |
|
|
|
|
|
|
|
|
|
|
domain |
4 |
|
|
|
|
|
|
|
|
|
|
paradigm |
4 |
|
|
|
|
|
|
|
|
|
|
oral |
4 |
|
|
|
|
|
|
|
|
|
|
identification |
4 |
|
|
|
|
|
|
|
|
|
|
neurotransmitter |
4 |
|
|
|
|
|
|
|
|
|
|
sea |
4 |
|
|
|
|
|
|
|
|
|
|
serious |
4 |
|
|
|
|
|
|
|
|
|
|
causes |
4 |
|
|
|
|
|
|
|
|
|
|
cd38 |
4 |
|
|
|
|
|
|
|
|
|
|
icos |
4 |
|
|
|
|
|
|
|
|
|
|
pd1 |
4 |
|
|
|
|
|
|
|
|
|
|
sensory |
4 |
|